Q. O O O O
What O O O O
is O O O O
a O O O O
coronavirus? O O O O
A: O O O O
Coronaviruses O O O O
are O O O O
a O O O O
large O O O O
family O O O O
of O O O O
viruses O O O O
that O O O O
can O O O O
be O O O O
found O O O O
broadly O O O O
across O O O O
mammals O O O O
and O O O O
birds. O O O O
They O O O O
are O O O O
named O O O O
after O O O O
the O O O O
crown-like O O O O
spike O O O O
proteins O O O O
that O O O O
surround O O O O
them. O O O O
They O O O O
typically O O O O
cause O O O O
limited O O O O
disease O O O O
in O O O O
their O O O O
host O O O O
species, O O O O
but O O O O
they O O O O
can O O O O
occasionally O O O O
mutate O O O O
and O O O O
cross O O O O
species O O O O
into O O O O
humans, O O O O
causing O O O O
diseases O O O O
that O O O O
range O O O O
in O O O O
symptoms O O O O
and O O O O
severity. O O O O
Q. O O O O
Why O O O O
is O O O O
COVID-19 O O O O
so O O O O
infectious? O O O O
A: O O O O
The O O O O
spikes O O O O
in O O O O
the O O O O
coronavirus O O O O
are O O O O
how O O O O
the O O O O
virus O O O O
attaches O O O O
to O O O O
their O O O O
host O O O O
cell. O O O O
The O O O O
stickier O O O O
the O O O O
spike, O O O O
the O O O O
more O O O O
efficient O O O O
the O O O O
virus O O O O
is O O O O
at O O O O
infecting O O O O
and O O O O
spreading. O O O O
SARS-CoV-2, O O O O
the O O O O
virus O O O O
that O O O O
causes O O O O
COVID-19, O O O O
has O O O O
spikes O O O O
that O O O O
stick O O O O
to O O O O
human O O O O
cells O O O O
like O O O O
Velcro, O O O O
forming O O O O
a O O O O
very O O O O
strong O O O O
bond O O O O
with O O O O
a O O O O
receptor O O O O
called O O O O
ACE2, O O O O
which O O O O
is O O O O
abundant O O O O
throughout O O O O
the O O O O
human O O O O
body. O O O O
These O O O O
strong O O O O
bonds O O O O
mean O O O O
less O O O O
SARS-CoV-2 O O O O
viruses O O O O
are O O O O
necessary O O O O
to O O O O
start O O O O
an O O O O
infection. O O O O
Q. O O O O
What O O O O
is O O O O
immunity O O O O
and O O O O
how O O O O
do O O O O
you O O O O
test O O O O
for O O O O
it? O O O O
A: O O O O
Immunity O O O O
is O O O O
when O O O O
the O O O O
body O O O O
is O O O O
able O O O O
to O O O O
resist O O O O
a O O O O
particular O O O O
disease. O O O O
The O O O O
standard O O O O
way O O O O
of O O O O
testing O O O O
for O O O O
immunity O O O O
to O O O O
a O O O O
virus O O O O
is O O O O
to O O O O
look O O O O
for O O O O
antibodies O O O O
to O O O O
the O O O O
virus O O O O
in O O O O
the O O O O
blood O O O O
(serology O O O O
tests) O O O O
following O O O O
infection. O O O O
Q. O O O O
What O O O O
are O O O O
antibodies? O O O O
A: O O O O
Antibodies O O O O
are O O O O
proteins O O O O
in O O O O
the O O O O
blood O O O O
produced O O O O
in O O O O
response O O O O
to O O O O
an O O O O
infection. O O O O
They O O O O
remain O O O O
as O O O O
protection O O O O
in O O O O
case O O O O
the O O O O
pathogen, O O O O
an O O O O
organism O O O O
that O O O O
causes O O O O
disease, O O O O
invades O O O O
the O O O O
body O O O O
again. O O O O
They O O O O
are O O O O
detectable O O O O
in O O O O
the O O O O
blood O O O O
approximately O O O O
five O O O O
to O O O O
seven O O O O
days O O O O
after O O O O
symptoms O O O O
begin O O O O
to O O O O
occur, O O O O
and O O O O
they O O O O
are O O O O
critical O O O O
to O O O O
the O O O O
body's O O O O
ability O O O O
to O O O O
fight O O O O
off O O O O
the O O O O
infectious O O O O
agent. O O O O
One O O O O
of O O O O
the O O O O
challenges O O O O
in O O O O
identifying O O O O
immunity O O O O
to O O O O
SARS-CoV-2 O O O O
is O O O O
that O O O O
scientists O O O O
are O O O O
still O O O O
working O O O O
to O O O O
learn O O O O
what O O O O
types O O O O
and O O O O
levels O O O O
of O O O O
antibodies O O O O
in O O O O
the O O O O
blood O O O O
are O O O O
sufficient O O O O
to O O O O
protect O O O O
against O O O O
reinfection O O O O
or O O O O
limit O O O O
the O O O O
effects O O O O
of O O O O
a O O O O
second O O O O
infection O O O O
by O O O O
rapidly O O O O
clearing O O O O
the O O O O
virus O O O O
out O O O O
of O O O O
the O O O O
body. O O O O
Q. O O O O
What O O O O
is O O O O
the O O O O
difference O O O O
between O O O O
IgM O O O O
and O O O O
IgG O O O O
antibodies? O O O O
A: O O O O
Immunoglobulin O O O O
M O O O O
(IgM) O O O O
is O O O O
the O O O O
first O O O O
antibody O O O O
that O O O O
is O O O O
produced O O O O
five O O O O
to O O O O
seven O O O O
days O O O O
after O O O O
infection. O O O O
A O O O O
high O O O O
prevalence O O O O
of O O O O
IgM O O O O
antibodies O O O O
versus O O O O
other O O O O
types O O O O
of O O O O
antibodies O O O O
suggests O O O O
an O O O O
active O O O O
infection. O O O O
When O O O O
someone O O O O
becomes O O O O
reinfected O O O O
with O O O O
the O O O O
same O O O O
strain O O O O
of O O O O
the O O O O
virus, O O O O
B O O O O
cells O O O O
that O O O O
make O O O O
these O O O O
IgG O O O O
antibodies O O O O
are O O O O
quickly O O O O
activated O O O O
and O O O O
produce O O O O
antibodies O O O O
more O O O O
rapidly O O O O
in O O O O
the O O O O
secondary O O O O
response O O O O
compared O O O O
to O O O O
the O O O O
primary O O O O
response. O O O O
Q. O O O O
Can O O O O
antibody O O O O
tests O O O O
prove O O O O
COVID-19 O O O O
immunity? O O O O
A: O O O O
There O O O O
is O O O O
encouraging O O O O
evidence O O O O
that O O O O
previous O O O O
exposure O O O O
to O O O O
SARS-CoV-2 O O O O
will O O O O
provide O O O O
protection O O O O
from O O O O
further O O O O
infection, O O O O
but O O O O
it O O O O
is O O O O
too O O O O
early O O O O
to O O O O
say O O O O
whether O O O O
individuals O O O O
who O O O O
have O O O O
the O O O O
disease O O O O
are O O O O
immune O O O O
to O O O O
reinfection, O O O O
or O O O O
how O O O O
long O O O O
that O O O O
protection O O O O
will O O O O
last. O O O O
Since O O O O
the O O O O
disease O O O O
has O O O O
only O O O O
been O O O O
infecting O O O O
humans O O O O
for O O O O
less O O O O
than O O O O
a O O O O
year, O O O O
it O O O O
will O O O O
take O O O O
more O O O O
time O O O O
to O O O O
answer O O O O
these O O O O
questions. O O O O
Q. O O O O
What O O O O
is O O O O
a O O O O
vaccine O O O O
and O O O O
how O O O O
does O O O O
it O O O O
work? O O O O
A: O O O O
A Reason 5 O O
vaccine Reason 5 O O
is Reason 5 O O
a Reason 5 O O
type Reason 5 O O
of Reason 5 O O
medicine Reason 5 O O
designed Reason 5 O O
to Reason 5 O O
protect Reason 5 O O
against Reason 5 O O
infectious Reason 5 O O
diseases Reason 5 O O
by Reason 5 O O
introducing Reason 5 O O
the Reason 5 O O
body's Reason 5 O O
immune Reason 5 O O
system Reason 5 O O
to Reason 5 O O
a Reason 5 O O
harmful Reason 5 O O
virus Reason 5 O O
or Reason 5 O O
bacteria Reason 5 O O
in Reason 5 O O
a Reason 5 O O
safe Reason 5 O O
way. Reason 5 O O
This Reason 5 O O
allows Reason 5 O O
the Reason 5 O O
immune Reason 5 O O
system Reason 5 O O
to Reason 5 O O
devise Reason 5 O O
strategies Reason 5 O O
to Reason 5 O O
defeat Reason 5 O O
it, Reason 5 O O
typically Reason 5 O O
by Reason 5 O O
generating Reason 5 O O
antibodies Reason 5 O O
to Reason 5 O O
proteins Reason 5 O O
specific Reason 5 O O
to Reason 5 O O
the Reason 5 O O
disease-causing Reason 5 O O
virus Reason 5 O O
or Reason 5 O O
bacteria. Reason 5 O O
Q. O O O O
Why O O O O
are O O O O
there O O O O
so O O O O
many O O O O
COVID-19 O O O O
vaccines O O O O
in O O O O
development? O O O O
Shouldn't O O O O
there O O O O
just O O O O
be O O O O
one? O O O O
A: O O O O
It Reason 4 O O
is Reason 4 O O
good Reason 4 O O
that Reason 4 O O
there Reason 4 O O
are Reason 4 O O
approximately Reason 4 O O
135 Reason 4 O O
vaccines Reason 4 O O
now Reason 4 O O
in Reason 4 O O
development Reason 4 O O
worldwide, Reason 4 O O
moving Reason 4 O O
at Reason 4 O O
a Reason 4 O O
pace Reason 4 O O
that Reason 4 O O
we Reason 4 O O
have Reason 4 O O
never Reason 4 O O
seen Reason 4 O O
before. Reason 4 O O
With Reason 4 O O
seven Reason 4 O O
billion Reason 4 O O
people Reason 4 O O
in Reason 4 O O
the Reason 4 O O
world, Reason 4 O O
multiple Reason 4 O O
vaccines Reason 4 O O
are Reason 4 O O
needed Reason 4 O O
so Reason 4 O O
that Reason 4 O O
they Reason 4 O O
can Reason 4 O O
be Reason 4 O O
successful Reason 4 O O
in Reason 4 O O
people Reason 4 O O
of Reason 4 O O
all Reason 4 O O
ages, Reason 4 O O
demographics Reason 4 O O
and Reason 4 O O
medical Reason 4 O O
needs. Reason 4 O O
Q. O O O O
How O O O O
do O O O O
you O O O O
determine O O O O
if O O O O
a O O O O
vaccine O O O O
is O O O O
successful? O O O O
A: O O O O
There Reason 4 O O
are Reason 4 O O
two Reason 4 O O
questions Reason 4 O O
that Reason 4 O O
scientists Reason 4 O O
must Reason 4 O O
answer Reason 4 O O
in Reason 4 O O
order Reason 4 O O
to Reason 4 O O
successfully Reason 4 O O
develop Reason 4 O O
a Reason 4 O O
vaccine: Reason 4 O O
- Reason 4 O O
Is Reason 4 O O
there Reason 4 O O
evidence Reason 4 O O
of Reason 4 O O
natural Reason 4 O O
protective Reason 4 O O
immunity Reason 4 O O
to Reason 4 O O
SARS-CoV-2 Reason 4 O O
after Reason 4 O O
an Reason 4 O O
individual Reason 4 O O
has Reason 4 O O
been Reason 4 O O
infected Reason 4 O O
and Reason 4 O O
recovered? Reason 4 O O
- Reason 4 O O
Is Reason 4 O O
there Reason 4 O O
evidence Reason 4 O O
that Reason 4 O O
a Reason 4 O O
vaccine Reason 4 O O
can Reason 4 O O
induce Reason 4 O O
immunity Reason 4 O O
in Reason 4 O O
subjects Reason 4 O O
who Reason 4 O O
have Reason 4 O O
not Reason 4 O O
been Reason 4 O O
exposed Reason 4 O O
to Reason 4 O O
the Reason 4 O O
virus, Reason 4 O O
and Reason 4 O O
if Reason 4 O O
so, Reason 4 O O
what Reason 4 O O
does Reason 4 O O
that Reason 4 O O
look Reason 4 O O
like Reason 4 O O
in Reason 4 O O
terms Reason 4 O O
of Reason 4 O O
types Reason 4 O O
and Reason 4 O O
numbers Reason 4 O O
of Reason 4 O O
antibodies? Reason 4 O O
[Learn O O O O
about O O O O
vaccines O O O O
that O O O O
Mass O O O O
General O O O O
is O O O O
developing](/news/coronavirus/research/vaccines/multiple-vaccines-best-way-stop-covid-19-pandemic) O O O O
Q. O O O O
Why O O O O
is O O O O
it O O O O
so O O O O
hard O O O O
to O O O O
develop O O O O
a O O O O
vaccine? O O O O
A: O O O O
A Reason 3 O O
key Reason 3 O O
challenge Reason 3 O O
in Reason 3 O O
developing Reason 3 O O
vaccines Reason 3 O O
for Reason 3 O O
emerging Reason 3 O O
infectious Reason 3 O O
diseases Reason 3 O O
is Reason 3 O O
that Reason 3 O O
each Reason 3 O O
pathogen Reason 3 O O
uses Reason 3 O O
a Reason 3 O O
different Reason 3 O O
mechanism Reason 3 O O
to Reason 3 O O
infect Reason 3 O O
cells Reason 3 O O
and Reason 3 O O
elicits Reason 3 O O
a Reason 3 O O
different Reason 3 O O
immune Reason 3 O O
response Reason 3 O O
from Reason 3 O O
the Reason 3 O O
body. Reason 3 O O
The Reason 3 O O
majority Reason 3 O O
of Reason 3 O O
vaccines Reason 3 O O
are Reason 3 O O
built Reason 3 O O
from Reason 3 O O
the Reason 3 O O
ground Reason 3 O O
up Reason 3 O O
to Reason 3 O O
address Reason 3 O O
these Reason 3 O O
unique Reason 3 O O
factors Reason 3 O O
and Reason 3 O O
need Reason 3 O O
to Reason 3 O O
undergo Reason 3 O O
rigorous Reason 3 O O
efficacy Reason 3 O O
and Reason 3 O O
safety Reason 3 O O
testingâ€”a Reason 3 O O
process Reason 3 O O
that Reason 3 O O
can Reason 3 O O
typically Reason 3 O O
take Reason 3 O O
up Reason 3 O O
to Reason 3 O O
six Reason 3 O O
years. Reason 3 O O
The Reason 3 O O
majority Reason 3 O O
of Reason 3 O O
vaccines Reason 3 O O
currently Reason 3 O O
being Reason 3 O O
tested Reason 3 O O
and Reason 3 O O
developed Reason 3 O O
rely Reason 3 O O
on Reason 3 O O
previous Reason 3 O O
research Reason 3 O O
addressing Reason 3 O O
other Reason 3 O O
types Reason 3 O O
of Reason 3 O O
infectious Reason 3 O O
diseases. Reason 3 O O
Q. O O O O
What O O O O
are O O O O
clinical O O O O
trials O O O O
and O O O O
why O O O O
are O O O O
they O O O O
important? O O O O
A: O O O O
Clinical O O O O
trials O O O O
are O O O O
scientific O O O O
studies O O O O
designed O O O O
to O O O O
test O O O O
the O O O O
safety O O O O
and O O O O
usefulness O O O O
of O O O O
new O O O O
medical O O O O
interventions O O O O
such O O O O
as O O O O
treatments, O O O O
devices, O O O O
preventative O O O O
care, O O O O
screening O O O O
or O O O O
diagnostic O O O O
procedures, O O O O
and O O O O
more. O O O O
There Reason 4 O O
are Reason 4 O O
four Reason 4 O O
phases Reason 4 O O
of Reason 4 O O
clinical Reason 4 O O
trials Reason 4 O O
that Reason 4 O O
each Reason 4 O O
inform Reason 4 O O
decisions Reason 4 O O
made Reason 4 O O
in Reason 4 O O
the Reason 4 O O
next Reason 4 O O
phase: Reason 4 O O
- Reason 4 O O
Phase Reason 4 O O
I: Reason 4 O O
Establishing Reason 4 O O
the Reason 4 O O
safety Reason 4 O O
and Reason 4 O O
correct Reason 4 O O
dosage Reason 4 O O
of Reason 4 O O
a Reason 4 O O
treatment Reason 4 O O
- Reason 4 O O
Phase Reason 4 O O
II: Reason 4 O O
Investigating Reason 4 O O
the Reason 4 O O
efficacy Reason 4 O O
and Reason 4 O O
side Reason 4 O O
effects Reason 4 O O
of Reason 4 O O
a Reason 4 O O
treatment Reason 4 O O
in Reason 4 O O
patients Reason 4 O O
with Reason 4 O O
the Reason 4 O O
disease Reason 4 O O
- Reason 4 O O
Phase Reason 4 O O
III: Reason 4 O O
Further Reason 4 O O
investigation Reason 4 O O
into Reason 4 O O
efficacy Reason 4 O O
and Reason 4 O O
monitoring Reason 4 O O
of Reason 4 O O
adverse Reason 4 O O
side Reason 4 O O
effects Reason 4 O O
- Reason 4 O O
Phase Reason 4 O O
IV: Reason 4 O O
Assess Reason 4 O O
the Reason 4 O O
cost-effectiveness Reason 4 O O
and Reason 4 O O
performance Reason 4 O O
of Reason 4 O O
a Reason 4 O O
treatment Reason 4 O O
in Reason 4 O O
real-life Reason 4 O O
scenarios Reason 4 O O
after Reason 4 O O
the Reason 4 O O
treatment Reason 4 O O
has Reason 4 O O
been Reason 4 O O
approved Reason 4 O O
by Reason 4 O O
the Reason 4 O O
U.S. Reason 4 O O
Food Reason 4 ScientificAuthority O
and Reason 4 ScientificAuthority O
Drug Reason 4 ScientificAuthority O
Administration Reason 4 ScientificAuthority O
[Learn O O O O
how O O O O
long O O O O
each O O O O
phase O O O O
can O O O O
take](https://mgriblog.org/2020/06/03/a-guide-to-understanding-clinical-trials-part-1-what-they-are-and-how-they-work/) O O O O
Q. O O O O
How Reason 2 O O
have Reason 2 O O
clinical Reason 2 O O
trials Reason 2 O O
for Reason 2 O O
COVID-19 Reason 2 O O
been Reason 2 O O
moving Reason 2 O O
so Reason 2 O O
quickly? Reason 2 O O
A: O O O O
In Reason 4 O O
the Reason 4 O O
interest Reason 4 O O
of Reason 4 O O
time Reason 4 O O
for Reason 4 O O
COVID-19, Reason 4 O O
instead Reason 4 O O
of Reason 4 O O
searching Reason 4 O O
for Reason 4 O O
a Reason 4 O O
new Reason 4 O O
treatment, Reason 4 O O
scientists Reason 4 O O
have Reason 4 O O
opted Reason 4 O O
to Reason 4 O O
test Reason 4 O O
treatments Reason 4 O O
that Reason 4 O O
have Reason 4 O O
already Reason 4 O O
been Reason 4 O O
approved Reason 4 O O
for Reason 4 O O
other Reason 4 O O
diseases Reason 4 O O
or Reason 4 O O
have Reason 4 O O
been Reason 4 O O
tested Reason 4 O O
in Reason 4 O O
humans Reason 4 O O
